Report for: In Polϴ position

Anna Dart (@annaedart) won the best paper title of the day: "In Polϴ position". Chapeaux! https://t.co/Oj1Fl49IzX

RT @NatureRevCancer: NEW (and our first ever) Journal Club 🎉! Hassan Brim & Hassan Ashktorab @HowardU discuss a paper that reported the inv…

RT @NatureRevCancer: NEW (and our first ever) Journal Club 🎉! Hassan Brim & Hassan Ashktorab @HowardU discuss a paper that reported the inv…

RT @NatureRevCancer: NEW (and our first ever) Journal Club 🎉! Hassan Brim & Hassan Ashktorab @HowardU discuss a paper that reported the inv…

starting something new at NRC! watch out for future ones too

NEW (and our first ever) Journal Club 🎉! Hassan Brim & Hassan Ashktorab @HowardU discuss a paper that reported the involvement of the #microbiome in colorectal cancer #metastasis. 📖 https://t.co/WzoFSvELIW @natrescancer https://t.co/xNOM3Vub8s

RT @NatureRevCancer: NEW #ResearchHighlight! Two studies published in @NatureCancer and @NatureComms describe the discovery of first-in-cla…

RT @NatureRevCancer: NEW #ResearchHighlight! Two studies published in @NatureCancer and @NatureComms describe the discovery of first-in-cla…

RT @NatureRevCancer: NEW #ResearchHighlight! Two studies published in @NatureCancer and @NatureComms describe the discovery of first-in-cla…

RT @NatureRevCancer: NEW #ResearchHighlight! Two studies published in @NatureCancer and @NatureComms describe the discovery of first-in-cla…

RT @NatureRevCancer: NEW #ResearchHighlight! Two studies published in @NatureCancer and @NatureComms describe the discovery of first-in-cla…

NEW #ResearchHighlight! Two studies published in @NatureCancer and @NatureComms describe the discovery of first-in-class, potent and specific inhibitors of Polϴ to target homologous recombination-deficient cancers. 📯 https://t.co/WzoFSvWn7w @natrescancer

In Polϴ position